SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-20-000004
Filing Date
2020-02-03
Accepted
2020-02-03 06:17:01
Documents
25
Period of Report
2020-02-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kregfd020320.htm 8-K 27418
2 EXHIBIT 99.1 ctibiopharma_corporatexp.htm EX-1 23970
3 ctibiopharma_corporatexp001.jpg GRAPHIC 50523
4 ctibiopharma_corporatexp002.jpg GRAPHIC 204792
5 ctibiopharma_corporatexp003.jpg GRAPHIC 109262
6 ctibiopharma_corporatexp004.jpg GRAPHIC 128159
7 ctibiopharma_corporatexp005.jpg GRAPHIC 96415
8 ctibiopharma_corporatexp006.jpg GRAPHIC 102800
9 ctibiopharma_corporatexp007.jpg GRAPHIC 110842
10 ctibiopharma_corporatexp008.jpg GRAPHIC 74490
11 ctibiopharma_corporatexp009.jpg GRAPHIC 116529
12 ctibiopharma_corporatexp010.jpg GRAPHIC 103757
13 ctibiopharma_corporatexp011.jpg GRAPHIC 131069
14 ctibiopharma_corporatexp012.jpg GRAPHIC 109627
15 ctibiopharma_corporatexp013.jpg GRAPHIC 122822
16 ctibiopharma_corporatexp014.jpg GRAPHIC 113616
17 ctibiopharma_corporatexp015.jpg GRAPHIC 132231
18 ctibiopharma_corporatexp016.jpg GRAPHIC 119624
19 ctibiopharma_corporatexp017.jpg GRAPHIC 79636
20 ctibiopharma_corporatexp018.jpg GRAPHIC 103275
21 ctibiopharma_corporatexp019.jpg GRAPHIC 123057
22 ctibiopharma_corporatexp020.jpg GRAPHIC 35195
23 ctibiopharma_corporatexp021.jpg GRAPHIC 61754
24 ctibiopharma_corporatexp022.jpg GRAPHIC 93675
25 ctibiopharma_corporatexp023.jpg GRAPHIC 54252
  Complete submission text file 0000891293-20-000004.txt   3328763
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 20566889
SIC: 2834 Pharmaceutical Preparations